Parexel Apex International Korea

PAREXEL is a proven and committed partner to drug developers and medical device manufacturers looking to bring innovative new products to market. Parrexel's Phase I-IV studies incorporate the full range of services from clinical study design to bioanalytics to peri-approval and post-marketing services, with an emphasis on First in Man and Proof of Concept studies. Parexel has decades of experience, deep expertise, and the global resources required to handle studies – and programs of studies – of any size, anywhere in the world.
PAREXEL operates in many of the emerging regions “Hot Spots”, such as, Latin America, Japan, Central & Eastern Europe, and Asia Pacific. In the last year there has been a 30% increase in clinical trials, which continues to increase dramatically.
PAREXEL offers an integrated, flexible approach with a unique fusion of expertise. Leveraging its global reach and eClinical technologies Parexel strives to efficiently develop products with the highest quality, safety and compliance in order to add value and help reach the goal of the pharmaceutical industry. Furthermore, in almost every instance Parexel can provide all the services you require without having to subcontract further. This means that Parexel is able to control the quality, integrity, and accuracy of every aspect of your Clinical Pharmacology study.

Type:	GOLDEN
Address:	3F, 510, Chung Hsiao E. Road, Section 5, Taipei, TAIWAN
Website:	www.parexel.com
Phone:	+886 2 2727 1100
Fax:	886 2 2346 521